Designed for clinical professionals, the Trial Interactive e-clinical platform is used by pharmaceutical, biotechnology, and CRO companies to streamline product development life cycles in a 21 CFR Part 11-compliant environment.
Clinipace CIO Michael Townley said: “We reviewed many solutions, and Trial Interactive offered the intuitive interface, transparency, hosting, support, and validation that was essential to our decision.
“The additional willingness to work with our other vendors and integration partners made Trial Interactive an obvious choice.”
The platform, which offers a fully integrated suite of solutions, also improves speed and quality across site identification and selection.
Additionally, Trial Interactive improves quality in personnel training, study start-up and site activation, eTMF management, and closeout and delivers clinical research-focused products that simplify tasks and audits/inspections.
TransPerfect president and CEO Phil Shawe said: “We are proud to have been selected by Clinipace to add our E-Feasibility and eTMF solutions to their technology stack.
“The studies they conduct are essential to bringing important treatments to market and improving patient lives.”
The Trial Interactive solution offers a web-based platform for clinical development that enables sponsors, CROs, IRBs, and other vendors to maintain and update clinical trial documentation securely.
It also streamlines study timelines and reduces the administrative burdens of global clinical trials.
Trial Interactive works with global clients as part of TransPerfect’s Life Sciences division and supports a range of requirements including e-feasibility, study start-up, eTMF review/reconciliation, mobile applications, among others.